We can certainly hope... but when it was valued @ $300MM, that had no effect whatsoever. The market may need more proof, such as investors buying up the IPO shares... or further vaccine progress.
Hopefully it at least causes a slow and steady rise that brings us into the 2/5 CC.
Here’s to hoping Joe timed the call to allow for some milestone in vaccine development!
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links